Literature DB >> 11817677

Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.

S Ohlsson1, I Ljungkrantz, K Ohlsson, M Segelmark, J Wieslander.   

Abstract

The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhibitor of, for example, elastase and cathepsin G, which also have antimicrobial capacity. SLPI has been localised to the respiratory, gastrointestinal and genital tracts, but so far not to the kidney. The presence of SLPI in renal tubuli cells was demonstrated using immunohistochemistry and, by means of in situ hybridisation on human renal biopsies, we were able to demonstrate SLPI production. In various inflammatory conditions in the kidneys, the protease-antiprotease balance is disturbed. For this reason, as well as the possible role in the defence against ascending urinary tract infections, it is interesting to establish a source of SLPI in renal tubuli cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817677      PMCID: PMC1781734          DOI: 10.1080/09629350120102389

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  11 in total

1.  Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage.

Authors:  S Ohlsson; B Tufvesson; A Polling; K Ohlsson
Journal:  Biol Chem       Date:  1997-09       Impact factor: 3.915

2.  Antibacterial activity of antileukoprotease.

Authors:  P S Hiemstra; R J Maassen; J Stolk; R Heinzel-Wieland; G J Steffens; J H Dijkman
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells.

Authors:  C Daniel; J Duffield; T Brunner; K Steinmann-Niggli; N Lods; H P Marti
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

4.  Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

Authors:  Y Zhang; D L DeWitt; T B McNeely; S M Wahl; L M Wahl
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages.

Authors:  C Sano; T Shimizu; K Sato; H Kawauchi; H Tomioka
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

6.  Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.

Authors:  T B McNeely; D C Shugars; M Rosendahl; C Tucker; S P Eisenberg; S M Wahl
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

7.  Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis.

Authors:  A N Elzouki; M Segelmark; J Wieslander; S Eriksson
Journal:  J Intern Med       Date:  1994-11       Impact factor: 8.989

8.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

9.  Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.

Authors:  M Bergenfeldt; L Axelsson; K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1992-12       Impact factor: 1.713

10.  Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.

Authors:  M Nyström; M Bergenfeldt; I Ljungcrantz; A Lindeheim; K Ohlsson
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more
  12 in total

Review 1.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Characterization of the ovine ortholog of secretory leukoprotease inhibitor.

Authors:  Thomas I Brown; Rohit Mistry; Robert Gray; Margaret Imrie; David D Collie; Jean-Michel Sallenave
Journal:  Mamm Genome       Date:  2005-09-14       Impact factor: 2.957

3.  MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.

Authors:  Akinobu Ochi; Dong Chen; Wibke Schulte; Lin Leng; Nickolas Moeckel; Marta Piecychna; Luisa Averdunk; Christian Stoppe; Richard Bucala; Gilbert Moeckel
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-24

4.  Urinary elafin and kidney injury in hematopoietic cell transplant recipients.

Authors:  Sangeeta Hingorani; Laura S Finn; Emily Pao; Rick Lawler; Gary Schoch; George B McDonald; Behzad Najafian; Brenda Sandmaier; Ted Gooley
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-11       Impact factor: 8.237

5.  Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.

Authors:  S Ohlsson; R Falk; J J Yang; K Ohlsson; M Segelmark; J Wieslander
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 6.  The innate immune response during urinary tract infection and pyelonephritis.

Authors:  John David Spencer; Andrew L Schwaderer; Brian Becknell; Joshua Watson; David S Hains
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

7.  Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics.

Authors:  Joshua Rowland; Artur Akbarov; James Eales; Xiaoguang Xu; John P Dormer; Hui Guo; Matthew Denniff; Xiao Jiang; Parisa Ranjzad; Alicja Nazgiewicz; Priscilla Ribeiro Prestes; Andrzej Antczak; Monika Szulinska; Ingrid A Wise; Ewa Zukowska-Szczechowska; Pawel Bogdanski; Adrian S Woolf; Nilesh J Samani; Fadi J Charchar; Maciej Tomaszewski
Journal:  Kidney Int       Date:  2019-03       Impact factor: 10.612

8.  SLPI - a Biomarker of Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm (TAAA) Repair.

Authors:  Christian Stoppe; Alexander Gombert; Luisa Averdunk; Marcia V Rückbeil; Alexander Zarbock; Lukas Martin; Gernot Marx; Houman Jalaie; Michael J Jacobs
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

9.  Identifying Biomarkers from Transcriptomic Signatures in Renal Allograft Biopsies Using Deceased and Living Donors.

Authors:  Bin Yang; Nicolas Sylvius; Jinli Luo; Cheng Yang; Zhanyun Da; Charlottelrm Crotty; Michael L Nicholson
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

10.  Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles.

Authors:  Julia Wilflingseder; Judith Sunzenauer; Eva Toronyi; Andreas Heinzel; Alexander Kainz; Bernd Mayer; Paul Perco; Gábor Telkes; Robert M Langer; Rainer Oberbauer
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.